XML 29 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2014
Financial Instruments  
Schedule of Disclosure About Significant Unobservable Inputs

 

 

Valuation Technique

 

Unobservable Input

 

Range (Weighted Average)

Market comparable companies

 

Enterprise value/Revenue multiple

 

2.4x – 6.6x (4.9x)

 

 

Discount applied to multiples

 

26% - 35% (27%)

 

 

 

 

 

Venture capital method

 

Enterprise value/EBITDA multiple

 

5.0x

 

 

Discount applied to enterprise value

 

55%

 

 

 

 

 

 

Unobservable Inputs — December 31, 2013

 

Valuation Technique

 

Unobservable Input

 

Range (Weighted Average)

Market comparable companies

 

Enterprise value/Revenue multiple

 

2.7x – 7.0x (5.5x)

 

 

Discount applied to multiples

 

30% - 35% (30%)

 

 

 

 

 

Venture capital method

 

Enterprise value/EBITDA multiple

 

5.0x

 

 

Discount applied to enterprise value

 

55%

Schedule of changes in the company's Level 3 financial instruments

 

 

(In thousands of dollars)

 

Balance at
December 31,
2013

 

Total gains or
(losses)
(realized and
unrealized)

 

Purchases

 

Sales

 

Settlements

 

Transfers in
and/or out of
Level 3

 

Balance at
March 31,
2014

 

Changes in
unrealized
gains/(losses)
on Level 3
assets still
held at the
reporting date

 

Investments

 

$

18,889

 

$

587

 

$

 

$

 

$

 

$

 

$

19,476

 

$

587